Century Therapeutics (IPSC) Research & Development (2022 - 2025)
Historic Research & Development for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $22.5 million.
- Century Therapeutics' Research & Development fell 1726.9% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.3 million, marking a year-over-year increase of 516.65%. This contributed to the annual value of $107.2 million for FY2024, which is 1567.68% up from last year.
- Per Century Therapeutics' latest filing, its Research & Development stood at $22.5 million for Q3 2025, which was down 1726.9% from $26.9 million recorded in Q2 2025.
- Century Therapeutics' Research & Development's 5-year high stood at $29.4 million during Q4 2024, with a 5-year trough of $21.2 million in Q1 2022.
- Over the past 4 years, Century Therapeutics' median Research & Development value was $24.9 million (recorded in 2023), while the average stood at $24.9 million.
- Per our database at Business Quant, Century Therapeutics' Research & Development soared by 3175.01% in 2024 and then plummeted by 1726.9% in 2025.
- Quarter analysis of 4 years shows Century Therapeutics' Research & Development stood at $25.6 million in 2022, then fell by 12.86% to $22.3 million in 2023, then soared by 31.75% to $29.4 million in 2024, then dropped by 23.32% to $22.5 million in 2025.
- Its Research & Development stands at $22.5 million for Q3 2025, versus $26.9 million for Q2 2025 and $26.6 million for Q1 2025.